If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
on lower limb revascularisation in low and middle income countries (LMICs). It has become increasingly apparent that the burden of vascular diseases disproportionally affects vulnerable and LMIC populations as a result of the epidemiological transition away from infectious diseases and towards non-communicable diseases, as a result of the rise in smoking, air pollution, obesity, diabetes, and trauma.
The resource constraints in rural or LMIC centres and local variation in vascular disease burden requires context appropriate guidelines informed by local practices, pathophysiology, and care accessibility. Efforts have been made to propose comprehensive guidelines for essential vascular care in LMICs
A recognition of the global surgical momentum by the vascular community will be essential to catalyse sustainable change, informed by data driven evidence, bilateral academic partnerships, and equitable practices. Now is the time to move towards the global vascular surgical tipping point to ensure that no patient is left behind.
Del Castro Madrazo J.A.
Outcomes of lower limb revascularisation in low and middle income countries.
Wijeyaratne et al. report outcomes of 367 patients undergoing lower extremity bypass for chronic limb threatening ischaemia (CLTI) in a university hospital in Sri Lanka.1 More than 202 million people are currently affected by peripheral arterial disease (PAD) worldwide.2 A 23.5% global increase was observed between 2000 and 2010, with a strikingly higher relative increase of PAD death rates and disability adjusted life years in low and middle income countries (LMICs) vs. high income countries.3
To submit a comment for a journal article, please use the space above and note the following:
We will review submitted comments as soon as possible, striving for within two business days.
This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
We require that commenters identify themselves with names and affiliations.